Charles Schwab’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Buy
437,175
+26,269
+6% +$862K ﹤0.01% 1930
2025
Q4
$13M Buy
410,906
+7,997
+2% +$240K ﹤0.01% 1998
2025
Q3
$9.47M Buy
402,909
+62,130
+18% +$1.06M ﹤0.01% 2147
2025
Q2
$3.87M Buy
340,779
+30,472
+10% +$289K ﹤0.01% 2440
2025
Q1
$2.06M Sell
310,307
-31,822
-9% -$297K ﹤0.01% 2609
2024
Q4
$3.77M Buy
342,129
+25,995
+8% +$319K ﹤0.01% 2471
2024
Q3
$3.89M Buy
316,134
+26,870
+9% +$381K ﹤0.01% 2492
2024
Q2
$3.91M Buy
289,264
+66,226
+30% +$894K ﹤0.01% 2453
2024
Q1
$3.01M Buy
223,038
+17,796
+9% +$108K ﹤0.01% 2476
2023
Q4
$1.08M Sell
205,242
-12,097
-6% -$51.7K ﹤0.01% 2801
2023
Q3
$856K Buy
217,339
+10,448
+5% +$68.7K ﹤0.01% 2848
2023
Q2
$2.2M Buy
206,891
+43,176
+26% +$459K ﹤0.01% 2515
2023
Q1
$1.36M Sell
163,715
-1,147
-0.7% -$10.3K ﹤0.01% 2632
2022
Q4
$1.52M Buy
164,862
+2,617
+2% +$27.2K ﹤0.01% 2644
2022
Q3
$2.08M Sell
162,245
-3,375
-2% -$53.8K ﹤0.01% 2575
2022
Q2
$2.19M Buy
165,620
+14,888
+10% +$226K ﹤0.01% 2544
2022
Q1
$3.17M Buy
150,732
+2,952
+2% +$59.1K ﹤0.01% 2485
2021
Q4
$3.55M Buy
147,780
+1,783
+1% +$42.5K ﹤0.01% 2523
2021
Q3
$3.71M Buy
145,997
+9,375
+7% +$261K ﹤0.01% 2509
2021
Q2
$4.6M Buy
136,622
+14,262
+12% +$504K ﹤0.01% 2392
2021
Q1
$4.75M Buy
122,360
+6,363
+5% +$362K ﹤0.01% 2328
2020
Q4
$7.18M Buy
115,997
+22,238
+24% +$1.02M ﹤0.01% 2046
2020
Q3
$3.14M Buy
93,759
+29,868
+47% +$853K ﹤0.01% 2308
2020
Q2
$1.52M Sell
63,891
-6,512
-9% -$155K ﹤0.01% 2507
2020
Q1
$1.61M Buy
70,403
+17,503
+33% +$432K ﹤0.01% 2351
2019
Q4
$1.5M Buy
52,900
+546
+1% +$13.7K ﹤0.01% 2487
2019
Q3
$1.13M Buy
+52,354
New +$1.46M ﹤0.01% 2534

Other funds holding STOK